Warns of consequences of no deal
'Optimisation' plans to reduce costs
Launching on International Women's Day
When it comes to finding growth in the UK, we are positive on the pharmaceuticals sector.
UK equities had a positive start to 2019. While this can be partly viewed as a rebound after 2018's difficult final quarter, what is likely to have been most significant is an extraordinary U-turn by the US Federal Reserve.
Optimism ahead of 29 March exit date